Lilly Poised to Own the Obesity Market; ADA 2023 Key Press Releases (June 26)
Here is a brief preview of this blast: On the last day of ADA 2023, nine cardiometabolic-related news items were observed from Lilly, Pfizer, Fractyl Health, Zealand Pharma, Vertex, Sernova, Senseonics, Dario, and GSK. Below, FENIX provides context and analysis for the announcements.